JPS56164119A - Immunostimulant medicine containing thymosin alpha1-fragment and thymosin alpha1-fragment - Google Patents

Immunostimulant medicine containing thymosin alpha1-fragment and thymosin alpha1-fragment

Info

Publication number
JPS56164119A
JPS56164119A JP398281A JP398281A JPS56164119A JP S56164119 A JPS56164119 A JP S56164119A JP 398281 A JP398281 A JP 398281A JP 398281 A JP398281 A JP 398281A JP S56164119 A JPS56164119 A JP S56164119A
Authority
JP
Japan
Prior art keywords
fragment
thymosin alpha1
immunostimulant
alpha1
medicine containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP398281A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0378374B2 (cg-RX-API-DMAC10.html
Inventor
Biru Kurisuchian
Shiyutorenbueruku Ururitsuhi
Buerunaa Irona
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Original Assignee
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV filed Critical Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Publication of JPS56164119A publication Critical patent/JPS56164119A/ja
Publication of JPH0378374B2 publication Critical patent/JPH0378374B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP398281A 1980-01-18 1981-01-16 Immunostimulant medicine containing thymosin alpha1-fragment and thymosin alpha1-fragment Granted JPS56164119A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3001775 1980-01-18

Publications (2)

Publication Number Publication Date
JPS56164119A true JPS56164119A (en) 1981-12-17
JPH0378374B2 JPH0378374B2 (cg-RX-API-DMAC10.html) 1991-12-13

Family

ID=6092418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP398281A Granted JPS56164119A (en) 1980-01-18 1981-01-16 Immunostimulant medicine containing thymosin alpha1-fragment and thymosin alpha1-fragment

Country Status (3)

Country Link
US (1) US4470926A (cg-RX-API-DMAC10.html)
JP (1) JPS56164119A (cg-RX-API-DMAC10.html)
DE (1) DE3066659D1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60104019A (ja) * 1983-11-10 1985-06-08 Fujisawa Pharmaceut Co Ltd ウイルス感染症用薬剤

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100974A1 (de) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4983387A (en) * 1986-05-19 1991-01-08 Viral Technologies Inc. HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
US5632983A (en) * 1994-11-17 1997-05-27 University Of South Florida Method for treating secondary immunodeficiency
AU2001268326A1 (en) * 2000-06-14 2001-12-24 Chanda Zaveri Peptides with physiological activity
US20070031372A1 (en) * 2004-08-05 2007-02-08 Hadden John W Vaccine immunotherapy for immune suppressed patients
US20060194242A1 (en) * 2000-10-27 2006-08-31 Hadden John W Immunotherapy for immune suppressed patients
CA2950109C (en) 2000-10-27 2019-02-19 John W. Hadden Vaccine immunotherapy for immune suppressed patients
US20070154399A1 (en) * 2000-10-27 2007-07-05 Hadden John W Immunotherapy for immune suppressed patients
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
US7182942B2 (en) * 2000-10-27 2007-02-27 Irx Therapeutics, Inc. Vaccine immunotherapy for immune suppressed patients
JP2005510491A (ja) * 2001-10-26 2005-04-21 イミュノ−アールエックス， インコーポレイテッド 免疫抑制を逆転させるための免疫治療
WO2009070639A1 (en) 2007-11-28 2009-06-04 Irx Therapeutics, Inc. Method of increasing immunological effect
AU2010248761B2 (en) 2009-05-15 2016-02-11 Irx Therapeutics, Inc. Vaccine immunotherapy
CN107050430B (zh) 2009-12-08 2021-10-15 伊尔克斯治疗有限公司 逆转朗格汉斯细胞免疫抑制的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60104019A (ja) * 1983-11-10 1985-06-08 Fujisawa Pharmaceut Co Ltd ウイルス感染症用薬剤

Also Published As

Publication number Publication date
JPH0378374B2 (cg-RX-API-DMAC10.html) 1991-12-13
US4470926A (en) 1984-09-11
DE3066659D1 (en) 1984-03-22

Similar Documents

Publication Publication Date Title
DE3176664D1 (en) Benzimidazoles and their pharmaceutical use
JPS5791921A (en) Medicine and manufacture
IL63880A0 (en) Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole
JPS57128622A (en) Nitroglycerin medicine medicine
JPS5750913A (en) Nifedipin-containing solid medicine and manufacture
GB8425079D0 (en) Tokens and handling devices
GB2079755B (en) Androstene 17 -carbonate 17 -carboxylates (and carbothioates)
JPS57118794A (en) Imunosome and preparation thereof
PH21847A (en) Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them
GB8308490D0 (en) Vials and syringes
DE3162761D1 (en) Triazoloquinoxalin-4-ones and such oxaline-4-thiones
JPS5718624A (en) Drug and manufacture
JPS57155657A (en) Microprocessor and associated devices
DE3367089D1 (en) 3-phenoxy-1-azetidinecarboxamides and their use and preparation
GB2070016B (en) 17-acyloxy-5-corticoids and 17-acyloxy-5-corticoids
ZW8781A1 (en) 2-nitroimidazoles and preparation thereof
NZ197072A (en) Carbapenams and carbapen-2-ems and pharmaceutical preparations
JPS5756429A (en) Nose medicine and manufacture
DE3164826D1 (en) Pharmaceutical preparations and manufacature
JPS56136560A (en) Medical injecting device
JPS5750897A (en) Xanthomonas canpestris atcc31601 and use
GB2089340B (en) -lactam antibiotics their preparation and their use
JPS57106613A (en) Pharmacetical medicine
GB2080307B (en) 6-fluorosteroids and their preparation
DE3266002D1 (en) Administering device